Coronary disease & ACS

Initial statin dose after myocardial infarction and long-term cardiovascular outcomes

Eur Heart J Cardiovasc PharmacotherPublished Retrospective cohort study

Authors' conclusion

Higher initial statin dose after MI is dose-dependently associated with better long-term cardiovascular outcomes.

Study context

Population
Consecutive myocardial infarction (MI) patients in Finland using statins early after index eventmedian follow-up 4.9 years
Participants
72,401 patients
Exposure
High- vs moderate- vs low-dose initial statin after MI
Outcome
MACCE
Follow-up
Within 10 years
Methodological detailsnational registries, multivariable-adjusted, Adjusted for baseline features, comorbidities, revascularisation and other evidence-based medications by multivariable regression
  • National registries
  • Multivariable-adjusted
  • Adjusted for baseline features, comorbidities, revascularisation and other evidence-based medications by multivariable regression

Main finding

As reported in the abstract

Adjusted hazard ratio

0.92

P < 0.0001

High dose vs Moderate dose · NNT 34.1

Adjusted hazard ratio

0.81

P < 0.001

High dose vs Low dose · NNT 13.4

Adjusted hazard ratio

0.88

P < 0.0001

Moderate dose vs Low dose · NNT 23.4

Observational data: associations, not effects.

Further findings

OutcomeEstimateP value
Death, recurrent MI, strokeHigh dose vs Moderate dose · death; NNT 23.6adjusted HR 0.87P < 0.0001
Death, recurrent MI, strokeHigh dose vs Moderate dose · recurrent MIadjusted sHR 0.91P = 0.0001
Death, recurrent MI, strokeHigh dose vs Moderate dose · strokeadjusted sHR 0.86P < 0.0001

Long-term outcomes by subgroup (age, sex, AF, dementia, DM, HF, revascularisation, prior statin, other medications)

Higher initial statin dose associated with better long-term outcomes in all subgroups

Original publication

Initial statin dose after myocardial infarction and long-term cardiovascular outcomes. Eur Heart J Cardiovasc Pharmacother. Published 16 November 2022. doi:10.1093/ehjcvp/pvac064

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.